Formulation of Modified Release Atorvastatin Nanoparticles by Emulsion Interfacial Reaction Method
DOI:
https://doi.org/10.37285/ijpsn.2015.8.3.7Abstract
The aim of the study is to formulate a modified release chitosan nanoparticles for the oral delivery of atorvastatin and to study the in vitro release of atorvastatin from chitosan nanoparticles. Atorvastatin-loaded chitosan nanoparticles were prepared with different concentration of cross-linking agent (glutaraldehyde) by emulsion interfacial reaction method. The formed nanoparticles were characterized in terms of size and morphological characteristics by scanning electron microscopy (SEM) and transmission electron microscope (TEM). Spherical and regular nanoparticles with the size range of 100-250nm were formed. Atorvastatin encapsulation efficiency of nanoparticles was found to be highest in ANP3, followed by ANP2 and ANP1. The in vitro release of atorvastatin was studied by membrane diffusion technique. The resulted cumulative percentage of drug released for ANP1, ANP2 and ANP3 were 60.08%, 34.81% and 20.39% respectively. Through this study, the nanoparticles preparation technique has shown to be a promising approach for enhancing the dissolution of hydrophobic drugs like atorvastatin calcium. The application of this novel delivery system offers good therapeutic potential in the management of hypercholesterolemia and dyslipidemia.
Downloads
Metrics
Keywords:
Hydrochlorothiazide, Metoprolol, Mannitol, Drug-drug dispersion, solubility
Downloads
Published
How to Cite
Issue
Section
References
A.V. Il’ina, V.P and Varlamov. (2010) Preparing, Studying, and Prospects of using Nanoparticles based on Chitosan and Galactomannan. Rossiiskie Nanoteknologii, 6(1-2): 154-160.
Allemann E, Gurny R and Doelker. (1993) Drug-loaded Nanoparticles-Preparation Methods and Drug Targeting Issues, Eur. J. Pharm. Biopharm, 39: 173-191.
Bhavna, V Sharma, M Ali, S Baboota and J Ali. (2007) Preparation And Characterization of Chitosan Nanoparticles for Nose to Brain Delivery of a Cholinesterase Inhibitor, Indian J of Pharm Sciences, 69(5): 712-713.
Catarina P.R, Ronald J.N, Antonio J.R and Francisco Veiga. (2006) Nanoencapsulation I. Methods for Preparation of Drug-loaded Polymeric Nanoparticles. Nanomedicine: Nanotechnology, Biology and Medicine, 2: 8– 21.
Gande Suresh, Kopparam Manjunath, Volbalaboina Venkateswarlu and Vemula Satyanarayana. (2008) Preparation, Characterization and in vitro and in vivo Evaluation of Lovastatin solid lipid nanoparticles, AAPS Pharm Sci Tech, 8(1): 24.
Hong-Liang Zhang, Si-Hui WU, Lin-Quan Zang and Zheng-Quan SU. (2010) Preparation and Characterization of Water-Soluble Chitosan Nanoparticles as Protein Delivery System. Journal of Nanomaterials,: art ID 898910.
Law M.R, Wald N.J and Rudnicka A.R. (2003) Quantifying Effect of Statins on Low Density Lipoprotein Cholesterol, Ischaemic Heart Disease And Stroke: Systematic Review and Meta-Analysis, Br. Med. J, 326: 1423-1427.
Lennernas H. (1997) Human Jejunal Effective Permeability and its Correlation with Preclinical Drug Absorption Models, J. Pharm. Pharmacol., 49: 627-638.
M.N. Kumar, R.A. Muzzarelli, C. Muzzarelli, H. Sashiwa, A.J. and Domb. (2004) Chitosan Chemistry and Pharmaceutical Perspectives, Chem. Rev, 104: 6017-6084.
M.R. Saboktakin, R.M. Tabatabaie, Abel Maharramov and M.A. Ramazanov. (2010) Synthesis and in vitro Evaluation of Thiolated Chitosan-Dextran Sulfate Nanoparticles for the Delivery of Letrozole, Pharm Educ Res, 1(2): 62-67.
Mallareddy Vandana and Sanjeeb K Sahoo. (2009) Optimization of Physicochemical Parameters Influencing the Fabrication of Protein-Loaded Chitosan Nanoparticles, Nanomedicine, 4(7): 773-785.
Manish P. Patel, Ravi R. Patel and Jayvadan K. Patel. (2010) Chitosan Mediated Targeted Drug Delivery System: A Review, J Pharm Sci, 13(3): 536-557.
Meenakshi Malhotra, Ciaran Lane, Catherine, Tomaro-Duchesneau, Shyamali Saha and Satya Prakash (2011). A Novel Method for Synthesizing Pegylated Chitosan Nanoparticles: Strategy, Preparation and In Vitro Analysis, Int. J of Nanomedicine, 6: 485-494.
Mohammed Anwar, Musarrat H.W, Neha Mallick, Sohail Akhter, Sachin Gahoi, Gaurav K. Jain, Sushma Talegaonkar, Farhan J.A and Roop K. Khar (2011). Enhanced Bioavailability of Nano-sized Chitosan–atorvastatin Conjugate after Oral Administration to rats, European J Pharm Sci, 44: 241-249.
Ping Li, Ya-Ni Dai, Jun-Ping Zhang, Ai-Qin Wang and Qin Wei (2008). Chitosan–Alginate nanoparticles as a Novel Drug delivery system for Nifedipine, Int J Biomed Sci, 4(3): 221-228.
V.J Mohanraj and Y Chen (2006). Nanoparticles – A review, Tropical Journal of Pharmaceutical Research, 5(1): 561-573.
Waree Tiyaboonchai (2003). Chitosan nanoparticles: A Promising System for Drug Delivery, Naresuan University Journal, 11(3): 51-66.
Wu.X., Whitfield L.R, and Stewart B.H (2000). Atorvastatin Transport in the Caco-2 Cell Model: Contributions of P-Glycoprotein and the Proton-Monocarboxylic Acid Co Transporter, Pharm. Res, 17: 209-215.
X.Y. Zhang, D.Y. Teng, Z.M. Wu, X. Wang, Z. Wang, D.M. Yu and C.X. Li (2008). PEG-grafted Chitosan Nanoparticles as an Injectable Carrier for Sustained Protein Release, J Mater Sci: Mater Med, 19: 3525-3533.
